Gene Query: MBD3

Dataset Description Geneva Score
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 53.71
Studying the selectivity of a small molecule Synucleozid on transcriptome 44.74
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 32.98
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 32.39
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 31.35
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 30.72
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 30.59
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 30.36
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 24.82
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 24.62
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 24.62
RNA transcriptome analysis during HSV-1 infection 24.55
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 24.45
A role for ZNF598 in post-transcriptional gene regulation 23.58
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 23.53
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 23.33
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 23.33
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 22.78
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 22.37
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 21.77
Genome-wide functional assessment of enhancer activities in the human genome 21.65
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 21.5
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 21.5
DART-seq: an antibody-free method for global m6A detection 21.46
Differential gene expression of human melanoma cells [RNA-seq] 21.28
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 21.28
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 20.76
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 20.0
MOF acetyl transferase regulates transcription and respiration in mitochondria 19.84
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 19.1
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 18.67
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 18.47
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 18.47
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 18.3
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 18.3
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 18.21
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 18.21
Transcriptome analysis of Zika infected neural stem cells 18.11
Zika infected neural stem cells 18.11
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 17.89
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 17.7
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 17.41
Peptidomimetic blockade of MYB in acute myeloid leukemia 17.41
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 17.41
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 17.4
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 17.4
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 17.01
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 16.93
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 16.83
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 16.74
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 16.67
Systematic discovery of endogenous human ribonucleoprotein complexes 16.61
HBEC-shp53-PCHD7 16.52
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 16.44
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 16.4
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 16.4
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 16.39
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 16.32
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 16.27
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 16.08
RNA-seq of cells with TET1 knockout 16.03
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 15.68
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 15.68
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 15.61
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 15.59
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 15.57
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 15.37
N6-methyladenine DNA Modification in Glioblastoma 15.27
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 15.27
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 15.25
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 15.13
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 14.94
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 14.88
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.5
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 14.43
High-Throughput Kinetic Analysis of Fractional Killing 14.38
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 14.36
AUF-1 affected genes in human skin cells 13.93
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 13.72
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 13.72
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 13.72
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 13.61
SNHG5 siRNA knock down in HCT116 cells 13.48
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 13.48
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 13.33
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 13.12
The evolution of N6-methyladenosine in primates 13.06
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 12.92
SLAM-seq for K562 endogenous mRNA decay 12.91
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 12.75
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 12.67
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 12.65
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 12.58
Mechanistic Model-Guided Study of Embryonic Morphogenesis 12.45
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 12.44
RNA-seq of YB5 cells treated with Proscillaridin A 12.4
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 12.29
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 12.27
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 12.13
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 12.07
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 12.05
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 11.99
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 11.86
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 11.82
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 11.77
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 11.77
Aneuploidy triggers an immune response 11.51
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 11.47
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 11.36
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 11.34
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.25
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 11.19
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 11.19
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 11.18
High-throughput sequencing of pluripotent cells 11.17
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.15
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 11.04
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 11.02
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 11.02
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 10.99
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 10.99
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 10.99
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 10.99
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 10.92
Genome wide expression change in LCC2 and MCF-7 cells 10.85
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 10.8
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 10.74
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 10.73
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.7
RNA-seq analyisis of PUM2 knockout cells 10.63
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 10.55
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 10.55
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 10.54
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 10.54
Lysine benzoylation is a novel histone mark 10.41
Lysine benzoylation is a novel histone mark [RNA-seq] 10.41
Role of XRN2 ribonucleolytic activity in RNA metabolism 10.39
Transcriptional profiling of microglia; current state of the art and future perspectives 10.36
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.36
RNA sequencing of BT142 and TS603 cell lines 10.35
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 10.35
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.18
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 10.18
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 10.17
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 10.06
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 10.05
hTERT promotes cell adhesion and migration independent of telomerase activity 10.05
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.05
METTL3 promotes translation in human cancer cells 10.02
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 9.96
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.95
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.93
G-quadruplex structures mark human regulatory chromatin 9.91
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 9.9
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.88
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.83
mRNA-Seq profiling of human developing kidney 9.73
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 9.67
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 9.67
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.66
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 9.61
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 9.6
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 9.59
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 9.58
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 9.41
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 9.37
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 9.35
Endothelial gene expression analysis 9.35
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 9.23
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 9.23
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 9.23
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 9.15
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.11
Effect of FGF13 depletion on the H460 cell line 9.1
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.0
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 9.0
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.99
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.99
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 8.97
Silencing p300 in MCF7 cells to study expression and alternative splicing 8.96
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 8.96
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.95
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 8.92
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.92
Rorc disruption in human FG pancreatic cancer cells 8.91
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 8.87
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.84
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 8.82
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 8.78
An integrative analysis of non-coding regulatory DNA variations associated with autism 8.78
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.77
8.76
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 8.76
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 8.75
Lipid degradation promotes prostate cancer cell survival 8.72
K562 polyA RNA-Seq 8.71
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 8.69
Differential responses of human fetal brain neural stem cells to Zika virus infection 8.68
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 8.63
Mutational landscape of splicing genes and functional consequences across 33 cancer types 8.61
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 8.59
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 8.56
MYC dependent mRNA translation shapes gene expression and cell biology 8.55
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 8.52
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 8.52
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 8.5
A code of mono-phosphorylation modulates the function of RB. 8.46
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 8.43
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.39
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.34
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 8.26
Hepatitis C virus functionally sequesters miR-122 8.2
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 8.2
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 8.2
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.17
Differential Protein Occupancy Profiling of the mRNA Transcriptome 8.16
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 8.13
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 8.06
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 8.06
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 7.99
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 7.96
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.96
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 7.96
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.95
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.85
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 7.79
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 7.77
Gene induction by the USP6 oncogene in response to interferon 7.77
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.77
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 7.77
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 7.75
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 7.75
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 7.75
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 7.71
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 7.68
HNRNPM-regulated splicing dependencies in prostate cancer 7.62
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 7.62
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 7.6
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 7.59
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 7.53
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.49
Disruption of the exocyst induces podocyte loss and dysfunction 7.49
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.47
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.46
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.46
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.46
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 7.46
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.37
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.36
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.35
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 7.29
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 7.27
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 7.26
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 7.24
Regulation of poly(A) tail and translation during the somatic cell cycle 7.2
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 7.16
Total RNA sequencing of WT intestinal orgaonids. 7.13
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 7.12
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 7.1
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 7.03
Identification of HOXB13 target genes responsive to BET inhibitors 7.03
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.99
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 6.98
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 6.98
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.98
A practical evaluation of alignment algorithms for RNA variant calling analysis 6.98
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 6.93
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 6.92
Ebola virus (EBOV) infection of ARPE-19 cells 6.8
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.71
Splicing and epigenetic factors jointly regulate epidermal differentiation 6.67
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 6.66
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 6.63
The effect of insulin on mRNA transcription of human pluripotent stem cells 6.59
Transcriptome of activated human and mouse MAIT cells 6.58
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 6.55
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 6.53
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 6.53
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 6.51
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.46
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.46
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 6.46
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 6.42
RIG-I and MDA5 fRIP during KSHV lytic reactivation 6.38
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.32
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 6.31
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.3
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.3
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.2
Transcriptome sequencing of K-562 cells 6.18
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 6.11
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 6.09
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 6.04
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.98
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.97
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.92
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 5.88
DAOY-Notch1/Notch2 knockout: transcriptome comparison 5.75
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.6
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.56
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 5.56
Global response to chemotherapy-induced apoptosis 5.48
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.46
Expression charcaterization of an internal protocol developed to differentiate RPE cells 5.4
RNA polymerase in pre-B-ALL cell lines 5.39
Functional role of CPPED1 in trophoblasts. 5.39
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.37
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.37
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 5.34
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 5.34
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 5.31
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 5.31
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 5.29
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 5.29
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 5.2
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 5.2
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.18
SRSF1 role in cellular gene expression and splicing 5.13
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 5.11
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 5.06
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.92
Transcriptome Profiling of Human Primary Monocytes 4.89
Effect of PBK knockdown on C4-2 cell transcriptome 4.85
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 4.82
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.78
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.75
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 4.66
ChIP-seq and RNA-seq from human lymphoma cell lines 4.63
RNA-seq data from human lymphoma cell lines 4.63
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.61
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.6
PRDM1 inhibits proliferation of human colon cancer organoids 4.6
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.6
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 4.46
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 4.43
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 4.43
Gene expressions of H9s in different culture systems 4.4
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.39
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.33
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 4.31
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 4.3
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 4.3
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 4.28
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.26
Gene expression analysis upon mtDNA depletion 4.26
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 4.25
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 4.24
Illumina Total RNA-seq in HeLa 4.21
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 4.21
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.2
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 4.19
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 4.12
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.12
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.12
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 4.11
RNA-seq analysis upon ARID1B overexpression 4.11
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.1
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 4.1
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 4.06
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.01
METTL3 and WTAP 3.93
Gene expression analysis of human hepatocellular cancers 3.91
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.81
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 3.81
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 3.79
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.76
Genome-wide discovery of human splicing branchpoints 3.73
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.72
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.67
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 3.65
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.63
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 3.61
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.6
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.6
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 3.54
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.51
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.51
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.4
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.4
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.36
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.28
MARS Seq data from human cortical organoids 3.22
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.2
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.18
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.18
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.15
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.14
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 3.11
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.03
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.0
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.98
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.97
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.96
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 2.91
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.86
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.81
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.81
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.78
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.78
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.76
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.61
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.6
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.49
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.45
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.43
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.43
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 2.36
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.36
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.36
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.35
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.14
Androgen Receptor-regulated genes in prostate cancer cells 2.14
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.13
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.08
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.07
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.06
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.04
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.0
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.0
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 1.98
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.98
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.97
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.93
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.92
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.89
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.89
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.79
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.7
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.68
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.68
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.63
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  1.6
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 1.59
Identification of differentially expressed genes between senescence and senescence bypass cells 1.58
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.55
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.52
hESC neural differentiation 1.51
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.51
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.48
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.48
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.45
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.39
Toxoplasma gondii infection of human retinal pigment epithelial cells 1.35
The pioneer factor CEBPA modulates vitamin D signaling 1.34
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.34
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.33
Gene expression profile in breast cancer cells 1.29
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.29
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.23
Investigate A2M treatment on human prostate cancer xenograft in mice 1.23
Investigate A2M treatment on human prostate cancer and mouse liver 1.23
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.2
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.19
Energy Metabolism during Anchorage-Independence 1.18
Regulation of hypoxia-inducible factor activity by ZMYND8 1.13
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.12
Comparative Analysis of Cas9 Activators Across Multiple Species 1.08
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.07
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.07
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.07
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.06
miRNAs affected by antagomiR-17 treatment 1.05
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.98
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 0.96
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.9
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.88
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.83
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.82
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.81
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.72
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.69
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.67
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.67
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.66
Transcriptome-wide modulation of splicing by the exon junction complex 0.65
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.62
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.59
Ribosome profiling upon inhibition of eIF4A 0.52
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.44
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.42
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.39
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.39
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.38
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.38
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.32
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.23
The circadian transcriptional landscape in primary human mammary epithelial cells 0.23
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.21
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.21
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.18
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.17
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.17
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.14
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.13
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.07
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
Enhancer activation during EGF response 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation